Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The madsen aurical.

Baer JE, Groth J.

Trends Amplif. 1998 Dec;3(4):152-61. doi: 10.1177/108471389800300404. No abstract available.

2.

Glycine-induced hyponatremia in the rat: a model of post-prostatectomy syndrome.

Silver SM, Kozlowski SA, Baer JE, Rogers SJ, Sterns RH.

Kidney Int. 1995 Jan;47(1):262-8.

3.

Clinical application of otoacoustic emissions: what do we know about factors influencing measurement and analysis?

Hall JW 3rd, Baer JE, Chase PA, Schwaber MK.

Otolaryngol Head Neck Surg. 1994 Jan;110(1):22-38. Review.

PMID:
8290298
4.

Dynamic sensorineural hearing loss: implications for audiologists: case reports.

Hall JW 3rd, Bratt GW, Schwaber MK, Baer JE.

J Am Acad Audiol. 1993 Nov;4(6):399-411.

PMID:
8298176
5.

Current concepts in hearing assessment of children and adults.

Hall JW 3rd, Baer JE.

Compr Ther. 1993;19(6):272-80. Review. No abstract available.

PMID:
8293658
6.

Drug-induced modifications of the immune response. 12. 4,5-Dihydro-4-oxo-2-(substituted amino)-3-furancarboxylic acids and derivatives as novel antiallergic agents.

Mack RA, Zazulak WI, Radov LA, Baer JE, Stewart JD, Elzer PH, Kinsolving CR, Georgiev VS.

J Med Chem. 1988 Oct;31(10):1910-8.

PMID:
3172125
7.

Ovary volume in young and premenopausal adults: US determination. Work in progress.

Munn CS, Kiser LC, Wetzner SM, Baer JE.

Radiology. 1986 Jun;159(3):731-2.

PMID:
3517957
8.

2-(Aminomethyl)phenols, a new class of saluretic agents. 4. Effects of oxygen and/or nitrogen substitution.

Stokker GE, Deana AA, deSolms SJ, Schultz EM, Smith RL, Cragoe EJ Jr, Baer JE, Russo HF, Watson LS.

J Med Chem. 1982 Jun;25(6):735-42.

PMID:
7097728
9.

2-(Aminomethyl)phenols, a new class of saluretic agents. 3. Effects of functional group reorientation and modification.

Stokker GE, Deana AA, deSolms SJ, Schultz EM, Smith RL, Cragoe EJ Jr, Baer JE, Russo HF, Watson LS.

J Med Chem. 1981 Sep;24(9):1063-7.

PMID:
7288821
10.

2-(Aminomethyl)phenols, a new class of saluretic agents. 1. Effects of nuclear substitution.

Stokker GE, Deana AA, deSolms SJ, Schultz EM, Smith RL, Cragoe EJ Jr, Baer JE, Ludden CT, Russo HF, Scriabine A, Sweet CS, Watson LS.

J Med Chem. 1980 Dec;23(12):1414-27.

PMID:
7452697
11.

Uptake of the beta-adrenergic blocking agents propranolol and timolol by rodent brain: relationship to central pharmacological actions.

Tocco DJ, Clineschmidt BV, Duncan AE, deLuna FA, Baer JE.

J Cardiovasc Pharmacol. 1980;2(2):133-43. No abstract available.

PMID:
6171681
12.

Diflunisal renal clearance in anesthetized dogs: effect of probenecid, urine flow, and urine pH.

Baer JE, Breault GO, Russo HF.

Arch Int Pharmacodyn Ther. 1978 Oct;235(2):204-10.

PMID:
32854
13.

Cambendazole and nondrug macromolecules in tissue residues.

Baer JE, Jacob TA, Wolf FJ.

J Toxicol Environ Health. 1977 Mar;2(4):895-903.

PMID:
853544
14.

Pharmacokinetics of methyldopa in man.

Kwan KC, Foltz EL, Breault GO, Baer JE, Totaro JA.

J Pharmacol Exp Ther. 1976 Aug;198(2):264-77.

PMID:
781212
15.

3,5-disubstituted 1,2,3,4-triazoles, 1 new class of xanthine oxidase inhibitor.

Duggan DE, Noll RM, Baer JE, Novello FC, Baldwin JJ.

J Med Chem. 1975 Sep;18(9):900-5.

PMID:
808613
16.

The site and mode of action of some sulfonamide-derived diuretics.

Beyer KH Jr, Baer JE.

Med Clin North Am. 1975 May;59(3):735-50. No abstract available.

PMID:
1128017
17.

Monitoring of plasma levels of a hypolipemic agent.

Baer JE.

Clin Pharmacol Ther. 1974 Jul;16(1):272-3. No abstract available.

PMID:
4843317
18.

Bioavailability of indomethacin in man.

Baer JE, Hucker HB, Duggan DE.

Ann Clin Res. 1974;6(0):suppl 11:44-7. Review. No abstract available.

PMID:
4211834
19.

Role of drug metabolism in drug research and development: basic considerations.

Baer JE.

J Pharm Sci. 1972 Oct;61(10):1674-7. No abstract available.

PMID:
4627330
20.

Renal excretion and uricosuric properties of halofenate, a hypolipidemic-uricosuric agent, in the chimpanzee.

Fanelli GM Jr, Bohn DL, Reilly SS, Baer JE.

J Pharmacol Exp Ther. 1972 Feb;180(2):377-96. No abstract available.

PMID:
5010680
21.

Subcellular pharmacology of natriuretic and potassium-sparing drugs.

Baer JE, Beyer KH.

Prog Biochem Pharmacol. 1972;7:59-93. Review. No abstract available.

PMID:
4265143
22.

Effects of the chronic administration of amiloride hydrochloride (N-amidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride dihydrate) on electrolyte balance in the dog.

Goldman WJ, Skeggs HR, Scott W, Baer JE, Mattis PA.

J Pharmacol Exp Ther. 1971 Nov;179(2):438-46. No abstract available.

PMID:
5133613
23.

Employee health program for Federal workers.

Baer JE.

Am J Public Health Nations Health. 1970 Nov;60(11):2099-101. No abstract available.

24.

The potassium-sparing and natriuretic activity of N-amidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride dihydrate (amiloride hydrochloride).

Baer JE, Jones CB, Spitzer SA, Russo HF.

J Pharmacol Exp Ther. 1967 Aug;157(2):472-85. No abstract available.

PMID:
6039836
25.

Enzymes, drugs and transport phenomena.

Beyer KH Jr, Baer JE.

Protoplasma. 1967;63(1):113-20. No abstract available.

PMID:
6037179
26.

[The effect of 2,3-dichlor-4-(2-methylene butyryl)-phenoxy-acetic acid (Ethacrynic acid) on urine concentration and renal solute gradients in dogs].

Baer JE, Michaelson JK, Jones CB, Russo HF, Beyer KH.

Arzneimittelforschung. 1966 Mar;16(3):373-80. German. No abstract available.

PMID:
6013848
27.

Renal pharmacology.

Baer JE, Beyer KH.

Annu Rev Pharmacol. 1966;6:261-92. Review. No abstract available.

PMID:
4953076
28.

MEMBRANE ADENOSINETRIPHOSPHATASE AND CATION COMPOSITION OF MAMMALIAN ERYTHROCYTES.

DUGGAN DE, BAER JE, NOLL RM.

Naturwissenschaften. 1965 May;52:264. No abstract available.

PMID:
14305706
29.

RENOTROPIC CHARACTERISTICS OF ETHACRYNIC ACID: A PHENOXYACETIC SALURETIC-DIURETIC AGENT.

BEYER KH, BAER JE, MICHAELSON JK, RUSSO HF.

J Pharmacol Exp Ther. 1965 Jan;147:1-22. No abstract available.

PMID:
14255159
30.

Letters to the Editor.

Baer JE.

Science. 1964 Feb 14;143(3607):639. No abstract available.

PMID:
17772608
31.

A NEW CLASS OF DIURETIC-SALURETIC AGENTS, THE ALPHA,BETA-UNSATURATED KETONE DERIVATIVES OF ARYLOXYACETIC ACIDS.

BAER JE, MICHAELSON JK, MCKINSTRY DN, BEYER KH.

Proc Soc Exp Biol Med. 1964 Jan;115:87-90. No abstract available.

PMID:
14117478
32.

SYNTHESIS AND DIURETIC ACTIVITY OF 3,3-SPIRO-SUBSTITUTED HYDROTHIAZIDES.

CRAGOE EJ Jr, WOLTERSDORF OW Jr, BAER JE, SPRAGUE JM.

J Med Pharm Chem. 1962 Sep;91:896-912. No abstract available.

PMID:
14056433
33.

Effect of hydrochlorothiazide on renal electrolyte gradient in glucose diuresis and experimental diabetes insipidus.

BAER JE, BROOKS AV, NOLL RM, BEYER KH.

J Pharmacol Exp Ther. 1962 Sep;137:319-23. No abstract available.

PMID:
13863868
34.

Physiological basis for the action of newer diuretic agents.

BEYER KH, BAER JE.

Pharmacol Rev. 1961 Dec;13:517-62. No abstract available.

PMID:
13868749
35.

Evaluation of diuretic agents.

BAER JE, BEYER KH.

Am J Pharm Sci Support Public Health. 1960 Jan;132:5-26. No abstract available.

PMID:
13795690
36.

The pharmacology of chlorothiazide and its analogues.

BEYER KH, BAER JE.

Int Rec Med Gen Pract Clin. 1959 Aug;172(8):413-26. No abstract available.

PMID:
13672676
37.

The physiological disposition of chlorothiazide (diuril) in the dog.

BAER JE, LEIDY HL, BROOKS AV, BEYER KH.

J Pharmacol Exp Ther. 1959 Apr;125(4):295-302. No abstract available.

PMID:
13642271
38.

Saluretic activity of hydrochlorothiazide (6-chloro-7-sulfamyl-3, 4-dihydro-1, 2,4-benzothiadiazine-1, 1-dioxide) in the dog.

BAER JE, RUSSO HF, BEYER KH.

Proc Soc Exp Biol Med. 1959 Mar;100(3):442-6. No abstract available.

PMID:
13634167
39.

Gastrointestinal secretion and absorption of 3-methylaminoisocamphane hydrochloride (mecamylamine).

ZAWOISKI EJ, BAER JE, BRAUNSCHWEIG LW, PAULSON SF, SHERMER A, BEYER KH.

J Pharmacol Exp Ther. 1958 Apr;122(4):442-8. No abstract available.

PMID:
13539770
40.

Electrolyte excretion as influenced by chlorothiazide.

BEYER KH Jr, BAER JE, RUSSO HF, NOLL R.

Science. 1958 Jan 17;127(3290):146-7. No abstract available.

PMID:
13495490
41.

Some normal laboratory values in the dog.

BAER JE, PECK HM, MCKINNEY SE.

Proc Soc Exp Biol Med. 1957 May;95(1):80-4. No abstract available.

PMID:
13431996
42.

Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine).

BAER JE, BEYER KH, PAULSON SF, RUSSO HF.

Am J Physiol. 1956 Jul;186(1):180-6. No abstract available.

PMID:
13354778
43.

Rate of turnover of epinephrine in the adrenal medulla.

UDENFRIEND S, COOPER JR, CLARK CT, BAER JE.

Science. 1953 Jun 12;117(3050):663-5. No abstract available.

PMID:
13056652
44.

Metabolic products of the cinchona alkaloids in human urine.

BRODIE BB, BAER JE, CRAIG LC.

J Biol Chem. 1951 Feb;188(2):567-81. No abstract available.

45.

The estimation of basic organic compounds in biological material; general principles.

BRODIE BB, UDENFRIEND S, BAER JE.

J Biol Chem. 1947 Apr;168(1):299-309. No abstract available.

PMID:
20291087
46.

Analysis of basic organic compounds in biological tissues; isolation prior to estimation.

BRODIE BB, UDENFRIEND S, BAER JE.

Fed Proc. 1946;5(1 Pt 2):124. No abstract available.

PMID:
21066639
47.

Cinchona alkaloids; metabolic products in human urine.

BRODIE BB, BAER JE, CRAIG LC.

Fed Proc. 1946;5(1 Pt 2):168. No abstract available.

PMID:
21064288

Supplemental Content

Support Center